Glory Health Industry Limited filed its Monthly Return for July 2026 on 5 August 2026, reporting no changes to authorised or issued share capital and confirming compliance with Hong Kong’s minimum public-float requirement.

The company’s authorised share capital remained 10.00 billion ordinary shares with a par value of HKD 0.001 each, equivalent to HKD 10.00 million. Issued shares (excluding treasury shares) stood unchanged at 4.44 billion, with no treasury shares on record. Consequently, total issued share capital also stayed at 4.44 billion shares.

Glory Health affirmed that the public float exceeded the initial prescribed threshold of 15%, satisfying Main Board Rule 13.32D(1). Throughout July, the issuer recorded zero movements under share option schemes, warrants, convertibles, or other equity-related arrangements, and reported no repurchases or cancellations.

All requisite confirmations under Main Board Rule 13.25C were provided by Chairman Zhang Zhangsun, indicating regulatory compliance across listing, disclosure and share-issuance obligations.